Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended		120 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Cash flows used in operating activities:
Net loss	$ (610,914)	$ (328,112)	$ (18,045,352)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,968	9,649	378,593
Original debt discount			450,000
Accretion of debt costs and beneficial conversion feature			1,237,263
Stock-based compensation	29,308	7,330	300,872
Research and development and professional expenses			44,750
Convertible debt issued for expenses			90,000
Bad debt expense			16,813
Decrease (increase) in:
Grants/other receivables	22,328	80,322	(38,281)
Prepaid expenses and other assets			(7,513)
Increase (decrease) in:
Accounts payable	(24,739)	(4,236)	52,442
Accrued liabilities	29,941	8,002	648,235
Net cash used in operating activities	(549,108)	(227,045)	(14,872,178)
Cash flows used in investing activities:
Purchase of property and equipment	(1,323)	(5,626)	(406,651)
Net cash used in investing activities	(1,323)	(5,626)	(406,651)
Cash flows from financing activities:
Proceeds from issuance of notes payable			5,240,000
Payments on notes payable	(15,000)		(90,000)
Issuance of preferred stock for cash			8,661,747
Issuance of common stock for cash	190,000		3,821,137
Proceeds from exercise of common stock options			9,800
Proceeds from exercise of preferred stock warrants			2,233
Net cash provided by financing activities	175,000		17,644,917
Net change in cash	(375,431)	(232,671)	2,366,088
Cash at beginning of the period	2,741,519	422,198
Cash at end of the period	2,366,088	189,527	2,366,088
Supplemental disclosure of cash flow information:
Cash paid for interest	2,020		7,454
Supplemental disclosure of noncash investing and financing activities:
The Company issued 219,658 shares of common stock in exchange for technology			220
The Company converted $1,050,000 of notes payable and $29,691 of accrued interest to 482,008 shares of Series A2 preferred stock			1,079,691
The Company converted $3,740,000 of notes payable and $370,346 of accrued interest to 1,787,104 shares of Series B preferred stock			4,110,346
The Company issued 19,457 shares of Series B preferred stock in exchange for $44,750 of research and development services provided			44,750
The Company issued $360,000 of convertible bridge notes payable with an original debt discount of $360,000. The discount was accreted as interest expense over the term of the note.			360,000
The Company issued $90,000 in convertible bridge notes payable for professional services provided, with an original debt discount of $90,000. The discount was accreted as interest expense over the term of the note			$ 90,000
The Company converted $900,000 of bridge notes payable and $16,644 of accrued interest to 916,644 shares of common stock.			916,644